DK169421B1 - Farmaceutisk præparat til oral indgift med kontrolleret afgivelse - Google Patents

Farmaceutisk præparat til oral indgift med kontrolleret afgivelse Download PDF

Info

Publication number
DK169421B1
DK169421B1 DK106685A DK106685A DK169421B1 DK 169421 B1 DK169421 B1 DK 169421B1 DK 106685 A DK106685 A DK 106685A DK 106685 A DK106685 A DK 106685A DK 169421 B1 DK169421 B1 DK 169421B1
Authority
DK
Denmark
Prior art keywords
granules
pharmaceutical composition
coated
granule
solution
Prior art date
Application number
DK106685A
Other languages
Danish (da)
English (en)
Other versions
DK106685D0 (da
DK106685A (da
Inventor
Tsutomu Irikura
Hiroshi Uchida
Jun Imai
Masakatsu Komuro
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of DK106685D0 publication Critical patent/DK106685D0/da
Publication of DK106685A publication Critical patent/DK106685A/da
Application granted granted Critical
Publication of DK169421B1 publication Critical patent/DK169421B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK106685A 1984-03-14 1985-03-08 Farmaceutisk præparat til oral indgift med kontrolleret afgivelse DK169421B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59048441A JPH0621066B2 (ja) 1984-03-14 1984-03-14 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
JP4844184 1984-03-14

Publications (3)

Publication Number Publication Date
DK106685D0 DK106685D0 (da) 1985-03-08
DK106685A DK106685A (da) 1985-09-15
DK169421B1 true DK169421B1 (da) 1994-10-31

Family

ID=12803438

Family Applications (2)

Application Number Title Priority Date Filing Date
DK106685A DK169421B1 (da) 1984-03-14 1985-03-08 Farmaceutisk præparat til oral indgift med kontrolleret afgivelse
DK057993A DK169096B1 (da) 1984-03-14 1993-05-18 Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK057993A DK169096B1 (da) 1984-03-14 1993-05-18 Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf

Country Status (11)

Country Link
US (1) US5151434A (fr)
EP (2) EP0156243B1 (fr)
JP (1) JPH0621066B2 (fr)
KR (1) KR850006130A (fr)
AU (1) AU582739B2 (fr)
DE (2) DE156243T1 (fr)
DK (2) DK169421B1 (fr)
IE (1) IE57853B1 (fr)
NZ (1) NZ211424A (fr)
PH (1) PH21996A (fr)
ZA (1) ZA851830B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
JPH01153634A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 吸入剤
JPH01153633A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 経皮吸収製剤
US5213800A (en) * 1989-02-09 1993-05-25 Diamond Scientific Company Chlorhexidine disinfectant granules
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
WO2000018374A1 (fr) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Liberation regulee de compositions nanoparticulaires
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US6720356B2 (en) * 2001-04-20 2004-04-13 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
JP5352452B2 (ja) * 2006-06-06 2013-11-27 メディシノバ， インコーポレイテッド 置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784683A (en) * 1971-03-29 1974-01-08 Abbott Lab Tablet preparation
JPS5229318B2 (fr) * 1972-03-30 1977-08-01
JPS5229318A (en) * 1975-09-01 1977-03-05 Nippon Telegraph & Telephone Type head for high speed printer or the like
CA1188505A (fr) * 1982-08-24 1985-06-11 Kenneth L. Hurley Dispositif d'alimentation en toner
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤

Also Published As

Publication number Publication date
KR850006130A (ko) 1985-10-02
IE850593L (en) 1985-09-14
DE3580774D1 (de) 1991-01-17
DK57993A (da) 1993-05-18
IE57853B1 (en) 1993-04-21
JPS60193913A (ja) 1985-10-02
EP0375662A3 (fr) 1990-11-07
PH21996A (en) 1988-05-02
EP0156243B1 (fr) 1990-12-05
AU3967685A (en) 1985-09-19
EP0375662A2 (fr) 1990-06-27
DK57993D0 (da) 1993-05-18
US5151434A (en) 1992-09-29
DK106685D0 (da) 1985-03-08
NZ211424A (en) 1988-09-29
DE156243T1 (de) 1986-05-22
AU582739B2 (en) 1989-04-13
EP0156243A2 (fr) 1985-10-02
ZA851830B (en) 1985-11-27
JPH0621066B2 (ja) 1994-03-23
DK106685A (da) 1985-09-15
DK169096B1 (da) 1994-08-15
EP0156243A3 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
DK169421B1 (da) Farmaceutisk præparat til oral indgift med kontrolleret afgivelse
JP4749639B2 (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
EP0122077B1 (fr) Composition pharmaceutique à effet retard
US6638535B2 (en) Modified release formulations containing a hypnotic agent
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
CA2321523C (fr) Procede utilisant des super-desintegrants dans la preparation de capsules ou de comprimes d'efavirenz a dissolution rapide
US5540945A (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
US6048547A (en) Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
IE862493L (en) Controlled release pharmaceutical preparations
CZ284924B6 (cs) Prostředek s řízeným uvolňováním, který obsahuje morfinovou sůl
CN109562072B (zh) 包括含有盐酸坦索罗辛的缓释丸粒的具有受控的溶出度的用于口服给药的药物制剂
JP2004510812A (ja) 遅延放出医薬製剤
PL206083B1 (pl) Farmaceutyczna postać dawkowania zawierająca chlorowodorek tamsulozyny, sposób wytwarzania farmaceutycznej postaci dawkowania oraz jej zastosowanie
KR20000069899A (ko) 속방성 및 미각 차폐성 약제학적 용량 형태
JP2011093938A (ja) 副作用が低減されたトラネキサム酸製剤
JP2002533396A (ja) 徐放性ガランタミン組成物
CA2011919A1 (fr) Materiel d'enrobage regulant la liberation d'une substance active pour les medicaments a action prolongee
JP2003510346A (ja) 新規医薬組成物
CA3107139C (fr) Compositions a liberation prolongee comprenant du trihexyphenidyle
EP0425699B1 (fr) Preparation orale pouvant etre liberee dans une region appropriee de l'intestin
WO1989002738A1 (fr) Preparation de nifedipine a liberation soutenue
PL192950B1 (pl) Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania
AU1456999A (en) Novel oral dosage form for carvedilol
CA2685214A1 (fr) Forme posologique orale a liberation regulee amelioree
WO2004058228A1 (fr) Composition de fluoxetine a enrobage enterique

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired